Kidney Biopsy Market Report 2026

Kidney Biopsy Market Overview

• Kidney Biopsy market size has reached to $2.26 billion in 2025 • Expected to grow to $2.86 billion in 2030 at a compound annual growth rate (CAGR) of 4.7% • Growth Driver: The Role Of Kidney Biopsy In Addressing The Surge In Renal Cancer Cases • Market Trend: Advancements in Artificial Intelligence Transforming Kidney Biopsy Analysis • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Kidney Biopsy Market?

A kidney biopsy, also known as a renal biopsy, is a medical procedure in which a small piece of kidney tissue is removed for microscopic examination. This procedure is typically performed to diagnose kidney conditions, assess the severity of known kidney diseases, or monitor the effectiveness of treatment. A kidney biopsy can help identify various kidney disorders, such as glomerulonephritis, interstitial nephritis, and nephrotic syndrome, and provide valuable information on the underlying causes of kidney dysfunction. The main types of kidney biopsy are percutaneous biopsy and surgical biopsy. Percutaneous biopsy involves inserting a needle through the skin to collect tissue samples from the kidney for examination. This method is employed across various indications, including kidney failure, kidney transplant, hematuria, and proteinuria, and is utilized by hospitals, clinics, urology centers, tertiary care centers, and other end-users.

What Is The Kidney Biopsy Market Growth Forecast?

The kidney biopsy market size is expected to see steady growth in the next few years. It will grow to $2.86 billion in 2030 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to increasing burden of diabetes-related kidney disorders, growing adoption of ultrasound- and ct-guided biopsy techniques, rising demand for early kidney disease diagnosis, advancements in imaging technologies, expanding access to specialized nephrology care. Major trends in the forecast period include growing preference for minimally invasive kidney biopsy procedures, rising use of image-guided percutaneous biopsies, increasing demand for accurate renal disease diagnosis, expansion of biopsy procedures in transplant monitoring, improved safety and precision in renal tissue sampling.

Global Kidney Biopsy Market Segmentation

1) By Type: Percutaneous Biopsy, Surgical Biopsy 2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria 3) By End-User: Hospitals And Clinics, Tertiary Care Centers, Other End-Users Subsegments: 1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy, CT-Guided Biopsy 2) By Surgical Biopsy: Open Kidney Biopsy, Laparoscopic Kidney Biopsy

What Is The Driver Of The Kidney Biopsy Market?

The rise in the incidence of renal cancer is expected to propel the growth of the kidney biopsy market going forward. Renal cancer is characterized by the uncontrolled growth of abnormal kidney cells. The rise in renal cancer is attributed to factors such as changes in lifestyle, environmental toxins, and better detection techniques that result in more diagnoses. A kidney biopsy helps diagnose and manage renal cancer by confirming the presence of cancerous cells, determining cancer grade, planning treatment, monitoring treatment response, and providing prognostic information. For instance, according to Cancer Research UK, a UK-based cancer research organization, the new kidney cancer cases are expected to increase from approximately 16,300 in 2023 to about 21,900 in 2025. Therefore, the rise in the incidence of renal cancer is driving the growth of the kidney biopsy industry.

Key Players In The Global Kidney Biopsy Market

Major companies operating in the kidney biopsy market are Cardinal Health, Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Hitachi Ltd., Canon Medical Systems Corporation, Cook Medical, B. Braun Melsungen AG, Merit Medical Systems Inc., Argon Medical Devices Inc., Stryker Corporation, Integra LifeSciences Corporation, Leica Biosystems, Hologic Inc., Samsung Medison Co. Ltd., Mindray Medical International Limited, Terumo Corporation, Fujifilm Holdings Corporation

Global Kidney Biopsy Market Trends and Insights

Major companies operating in the kidney biopsy market are developing innovative platforms by integrating with artificial intelligence (AI) to enhance diagnostic accuracy, streamline procedures, and improve patient outcomes. Artificial intelligence (AI) enhances kidney biopsy by improving image analysis, providing diagnostic support, aiding in treatment planning, offering predictive analytics, and advancing research in kidney diseases. For instance, in March 2024, Aiosyn, a Netherlands-based software company, launched the NephroPath platform. The NephroPath platform uses computational pathology algorithms to analyze histological biomarkers in kidney biopsies, including identifying tissue types, measuring interstitial fibrosis, and precisely counting and assessing glomeruli. This AI-driven analysis ensures consistent, detailed, and reproducible scoring of renal pathology biomarkers, overcoming the drawbacks of traditional scoring methods and observer subjectivity.

What Are Latest Mergers And Acquisitions In The Kidney Biopsy Market?

In March 2025, Aiosyn, a Netherlands-based pathology software company specializing in artificial intelligence (AI)-powered diagnostic solutions, partnered with Pramana to introduce real-time AI processing for kidney biopsy assessments. With this partnership, Aiosyn and Pramana aim to integrate Aiosyn’s NephroPath AI algorithms with Pramana’s digital pathology platform to accelerate kidney biopsy workflows, improve diagnostic accuracy through automated tissue quantification, and enhance efficiency by enabling on-device, edge-based processing. Pramana is a US-based digital pathology technology company specializing in automated whole-slide imaging systems with embedded edge-AI capabilities.

Regional Outlook

North America was the largest region in the kidney biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Kidney Biopsy Market?

The kidney biopsy market consists of revenues earned by entities by providing services such as diagnostic biopsy, therapeutic biopsy, post-biopsy care and monitoring, and pathological analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The kidney biopsy market also includes sales of biopsy needles, biopsy guns, biopsy trays and kits, and biopsy specimen containers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Kidney Biopsy Market Report 2026?

The kidney biopsy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the kidney biopsy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.